Angelmarin

Angelmarin

SCHEMBL29507688

CC(C)(OC(=O)/C=C/c1ccc(O)cc1)[C@@H]1Cc2c(ccc3ccc(=O)oc23)O1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.63
▸ HPGD P15428 7/20 0.63
▸ ALDH1A1 P00352 6/20 0.63
▸ LMNA P02545 1/20 0.63
▸ ABCB1 P08183 1/20 0.63
▸ GAA P10253 1/20 0.58
▸ HSD17B10 Q99714 3/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP3A4 P08684 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ POLB P06746 1/20 0.39
▸ NPY1R P25929 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ NPY2R P49146 1/20 0.39
▸ CA12 O43570 3/20 0.38
▸ CA1 P00915 3/20 0.38
▸ CA2 P00918 3/20 0.38
▸ CA7 P43166 3/20 0.38
▸ CA9 Q16790 3/20 0.38
▸ CA14 Q9ULX7 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Angelmarin SCHEMBL30443353 1.00 KDM4E (0.63) KDM4EHPGDALDH1A1LMNAABCB1
SCHEMBL30794498 0.82 KDM4E (0.74) KDM4EHPGDALDH1A1LMNAABCB1
SCHEMBL12247775 0.81 KDM4E (0.79) KDM4EHPGDALDH1A1LMNAABCB1
SCHEMBL31438609 0.81 KDM4E (0.79) KDM4EHPGDALDH1A1LMNAABCB1
Columbianadin SCHEMBL14424509 0.78 KDM4E (1.00) KDM4EHPGDALDH1A1LMNAABCB1
Columbianadin SCHEMBL27844678 0.78 KDM4E (1.00) KDM4EHPGDALDH1A1LMNAABCB1
SCHEMBL29390971 0.77 ABCB1 (1.00) KDM4EHPGDALDH1A1LMNAABCB1
Columbianetin SCHEMBL21527679 0.75 KDM4E (1.00) KDM4EHPGDALDH1A1LMNAABCB1
Columbianetin SCHEMBL20356593 0.75 KDM4E (1.00) KDM4EHPGDALDH1A1LMNAABCB1
SCHEMBL29386245 0.71 KDM4E (0.76) KDM4EHPGDALDH1A1LMNAABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025133858-A1 FUNCTIONAL NUCLEIC ACID MOLECULE CAPABLE OF INCREASING BDNF PRODUCTION FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2025-06-26 — — WO claimed
CN-113387930-B Bifunctional compound and preparation method and application thereof 苏州开拓药业股份有限公司 2022-07-12 — — CN claimed
US-20220195502-A1 METHOD FOR DETECTING SPECIFIC NUCLEIC ACIDS IN SAMPLES GENEPATH DIAGNOSTICS INC (US) 2022-06-23 — — US claimed
WO-2025133858-A1 FUNCTIONAL NUCLEIC ACID MOLECULE CAPABLE OF INCREASING BDNF PRODUCTION FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2025-06-26 — — WO disclosed
US-20240299932-A1 ORGANS-ON-CHIPS AS A PLATFORM FOR EPIGENETICS DISCOVERY EMULATE INC (US) 2024-09-12 — — US disclosed
US-12036548-B2 Organs-on-chips as a platform for epigenetics discovery EMULATE, Inc. (US) 2024-07-16 — — US disclosed
WO-2023033633-A1 NEURAL ACTIVITY MONITORING AND DIAGNOSIS USING EUKARYOTIC GROWTH FACTOR EEF2 PHOSPHORYLATION 서울대학교 산학협력단 2023-03-09 — — WO disclosed
CN-108291226-B Oligonucleotides for inducing paternal UBE3A expression 豪夫迈·罗氏有限公司 2022-11-04 — — CN disclosed
CN-113387930-B Bifunctional compound and preparation method and application thereof 苏州开拓药业股份有限公司 2022-07-12 — — CN disclosed
US-20220195502-A1 METHOD FOR DETECTING SPECIFIC NUCLEIC ACIDS IN SAMPLES GENEPATH DIAGNOSTICS INC (US) 2022-06-23 — — US disclosed
CN-114245805-A ALK7 binding proteins and uses thereof 艾科赛扬制药股份有限公司 2022-03-25 — — CN disclosed
Send feedback